Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-03

Clinical Trial Update: A Study of LP-128 Capsules in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating LP-128 capsules in healthy subjects is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LP-128 Capsules (LP-128)

Snippet

Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. | Conditions: Chronic Hepatitis b | Phase 1 | Status: ACTIVE_NOT_RECRUITING